Literature DB >> 22803713

Cryptosporidium parvum antigens induce mouse and human dendritic cells to generate Th1-enhancing cytokines.

B Bedi1, J R Mead.   

Abstract

Cryptosporidium parvum is an opportunistic intracellular parasite that causes mild to severe diarrhoea, which can be life-threatening in an immunocompromised host. To increase our understanding of the mechanisms that play a role in host immune responses, we investigated the effects of C. parvum antigens on the phenotype of mouse and human dendritic cells (DCs). Cryptosporidium parvum antigens induced DC activation as indicated by upregulation of the maturation marker CD209, as well as by the production of the cytokines interleukin-12 p70, IL-2, IL-1beta, IL-6. In particular, significant increases in the expression of IL-12 p70 were observed from mouse DCs derived from bone marrow in response to solubilized sporozoite antigen and the recombinant cryptosporidial antigens, Cp40 and Cp23. We observed a small but significant increase in IL-18 expression following the exposure to Cp40. We found that the induction of Th1 cytokines was MyD88 dependent (MyD88 knockout mouse DCs were unresponsive). Additionally, both sporozoite preparations (solubilized and live) significantly induced IL-12 production by human monocytic dendritic cells (MoDCs). This finding indicates that solubilized as well as recombinant antigens can induce the maturation of DCs and subsequently initiate an innate immune response.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803713     DOI: 10.1111/j.1365-3024.2012.01382.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  9 in total

1.  Systemic and Mucosal Immune Responses to Cryptosporidium-Vaccine Development.

Authors:  Jacob G Ludington; Honorine D Ward
Journal:  Curr Trop Med Rep       Date:  2015-09-01

2.  Sarcocystis fusiformis whole cyst antigen activates pro-inflammatory dendritic cells.

Authors:  K Connick; R Lalor; A Murphy; S M O'Neill; Eman E El Shanawany
Journal:  J Parasit Dis       Date:  2019-11-28

3.  Interaction of Cryptosporidium parvum with mouse dendritic cells leads to their activation and parasite transportation to mesenteric lymph nodes.

Authors:  Gregorio Perez-Cordon; Guilin Yang; Boping Zhou; Weijia Nie; Shan Li; Lianfa Shi; Saul Tzipori; Hanping Feng
Journal:  Pathog Dis       Date:  2013-09-10       Impact factor: 3.166

4.  Identification and characterization of a new 34 kDa MORN motif-containing sporozoite surface-exposed protein, Cp-P34, unique to Cryptosporidium.

Authors:  Justyna J Jaskiewicz; Jacqueline M Tremblay; Saul Tzipori; Charles B Shoemaker
Journal:  Int J Parasitol       Date:  2021-03-25       Impact factor: 4.330

5.  Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.

Authors:  Patrice N Mimche; Lauren M Brady; Shirley Keeton; David S J Fenne; Thayer P King; Kendra M Quicke; Lauren E Hudson; Tracey J Lamb
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

6.  Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate.

Authors:  John R Haserick; Joshua A Klein; Catherine E Costello; John Samuelson
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

7.  Revisiting the global problem of cryptosporidiosis and recommendations.

Authors:  Arpit Kumar Shrivastava; Subrat Kumar; Woutrina A Smith; Priyadarshi Soumyaranjan Sahu
Journal:  Trop Parasitol       Date:  2017 Jan-Jun

Review 8.  Lessons Learned from Protective Immune Responses to Optimize Vaccines against Cryptosporidiosis.

Authors:  Maxime W Lemieux; Karine Sonzogni-Desautels; Momar Ndao
Journal:  Pathogens       Date:  2017-12-24

Review 9.  The Mucosal Innate Immune Response to Cryptosporidium parvum, a Global One Health Issue.

Authors:  Charles K Crawford; Amir Kol
Journal:  Front Cell Infect Microbiol       Date:  2021-05-25       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.